Report : South & Central America Enteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
At 6.2% CAGR, the South & Central America Enteral Medical Nutrition Market is speculated to be worth US$ 625.02 Million by 2028, says Business Market Insights
According to Business Market Insights’ research, the South & Central America enteral medical nutrition market was valued at US$ 435.35 million in 2022 and is expected to reach US$ 625.02 million by 2028, registering an annual growth rate of 6.2% from 2022 to 2028. Use of next generation technology for proper enteral nutrition feeding is the critical factor attributed to the market expansion.
In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.
On the contrary, complications of enteral nutrition hurdle the growth of South & Central America enteral medical nutrition market.
- Based on indication, the South & Central America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. Respiratory disorders held 41.4% market share in 2022, amassing US$ 180.43 million. It is projected to garner US$ 252.69 million by 2028 to expand at 5.8% CAGR during 2022–2028.
- Based on nutrition type, the South & Central America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 76.2% market share in 2022, amassing US$ 331.80 million. It is projected to garner US$ 470.77 million by 2028 to expand at 6.0% CAGR during 2022–2028.
- Based on form, the South & Central America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held 55.1% market share in 2022, amassing US$ 240.00 million. It is projected to garner US$ 351.56 million by 2028 to expand at 6.6% CAGR during 2022–2028.
- Based on product, the South & Central America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held 52.5% market share in 2022, amassing US$ 228.58 million. It is projected to garner US$ 322.92 million by 2028 to expand at 5.9% CAGR during 2022–2028.
Based on distribution channel, the South & Central America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held 60.7% market share in 2022, amassing US$ 264.28 million. It is projected to garner US$ 377.14 million by 2028 to expand at 6.1% CAGR during 2022–2028.
- Based on Age Group, the South & Central America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). With 89.7% share of the domain, the adults segment dominated the market in 2022. It accrued US$ 390.44 million in 2022 and is estimated to generate US$ 556.61 million by 2028 to grow at a CAGR of 6.1% over the forecast period.
Our regional analysis states that Rest of SAM captured 38.0% market share in 2022. It was assessed at US$ 165.57 million in 2022 and is likely to hit US$ 233.19 million by 2028, exhibiting a CAGR of 5.9% during the forecast period.
Key players dominating the South & Central America enteral medical nutrition market are Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com